BeStock  
Stocks › Biotechnology › GMAB

Genmab GMAB

US equityMarket cap rank #628Biotechnology
$50.60 −$0.75 (-1.46%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $50.02 -1.15%
Open$51.57
Prev close$51.35
Day range$50.24 – $51.72
Volume2.90M
Market cap$31.20B
P/E (TTM)43.2
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership61.6%-0.25 pts vs. prior quarter
Institutions holding627-3 vs. prior quarter
Insider trades (recent)0 buys / 3 sellsNet selling
Short interest1.57% of floatDays to cover 1.2 · as of 30 Oct 2026
Short-sale volume share21.8%5-day average of daily volume

Short-sale volume as % of daily volume

8%16%25%33%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$18.64M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$1.6MSuper−$17.1MBig−$9.0MMid−$9.2MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 25.1% of shares outstanding.

Largest holders

  • BlackRock6.81%
  • Orbis Investment Management Limited6.67%
  • Darwin Global Management Limited5.71%
  • Vanguard Capital Management, LLC3.72%
  • Paradigm Biocapital Advisors LP2.23%
  • Wellington Management Group2.08%
  • AllianceBernstein2.02%
  • Baillie Gifford1.39%

By investor type

  • Mutual Fund42.53%
  • Hedge Fund12.90%
  • Government Pension Fund1.95%
  • VC/PE Fund1.51%
  • Sovereign Wealth Fund1.25%
  • Individual/Insider1.10%
  • Private Company0.66%
  • Public Company0.53%

Reported short interest has risen from 1.24% to 1.57% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
WCM Investment Management Mutual Fund 2026/Q3 +704,370 0.1%
Mackenzie Financial Corporation Mutual Fund 2026/Q3 +347,350 0.1%
Darwin Global Management Limited Hedge Fund 2026/Q4 +40,160,890 5.7%
Capital Research Mutual Fund 2026/Q4 +4,558,140 0.7%
Point72 Asset Management, L.P. Hedge Fund 2026/Q4 +3,399,440 0.6%
Holocene Advisors, LP Hedge Fund 2026/Q4 +2,316,390 0.4%
Two Sigma Investments, LP Hedge Fund 2026/Q4 +1,745,870 0.8%
Adage Capital Management, L.P. Hedge Fund 2026/Q4 +1,400,000 0.2%
BlackRock Mutual Fund 2026/Q4 +1,385,940 6.8%
Arrowstreet Capital, Limited Partnership Mutual Fund 2026/Q4 +1,093,950 1.0%
Paradigm Biocapital Advisors LP Hedge Fund 2026/Q4 +1,003,340 2.2%
Alyeska Investment Group, L.P. Hedge Fund 2026/Q4 +873,920 0.3%
Woodline Partners LP Hedge Fund 2026/Q4 +736,870 0.1%
Great Point Partners, LLC VC/PE Fund 2026/Q4 +525,000 0.1%
LMR Partners LLP Hedge Fund 2026/Q4 +480,800 0.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Nov 2026 Judith Klimovsky Chief Development Officer Intent to Sell (Form 144) -1,265 $556.78 –
16 Jun 2025 Judith Klimovsky Chief Development Officer Intent to Sell (Form 144) -1,300 $51.69 –
29 Feb 2024 Judith Klimovsky Chief Development Officer Intent to Sell (Form 144) -1,200 $27.77 –

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 9,659,086 1.6% 1.2
15 Oct 2026 6,598,711 1.1% 1.3
30 Sep 2026 6,062,007 1.0% 2.1
15 Sep 2026 4,920,530 0.8% 3.2
31 Aug 2026 6,830,174 1.1% 2.4
14 Aug 2026 7,598,057 1.2% 2.7

Discussion

No comments yet — be the first to weigh in on GMAB.

Sign in to join the discussion.

Scroll to Top